Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1973-7-19
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3549
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
858-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4705710-Aza Compounds,
pubmed-meshheading:4705710-Carcinoma, Squamous Cell,
pubmed-meshheading:4705710-Cells, Cultured,
pubmed-meshheading:4705710-Humans,
pubmed-meshheading:4705710-Leukemia,
pubmed-meshheading:4705710-Neoplasms, Experimental,
pubmed-meshheading:4705710-Purines,
pubmed-meshheading:4705710-Ribonucleosides,
pubmed-meshheading:4705710-Triazoles
|
pubmed:year |
1973
|
pubmed:articleTitle |
Carbocyclic analog of purine ribonucleosides with antileukemic activity.
|
pubmed:publicationType |
Journal Article
|